A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis

Cell Death and Differentiation

Volumn 6, Issue 4, 1999, Pages 326-333

  Rakkar, Amol N S ^a   Katayose, Yu ^a   Kim, Min ^a   Craig, Caroline ^a   Ohri, Ekta ^a   Li, Zhuangwu ^a   Cowan, Kenneth H ^a   Seth, Prem ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adenovirus; Apoptosis; Fas CD95 APO 1; Gene therapy; p53

Indexed keywords

FAS ANTIGEN; PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CORRELATION FUNCTION; CYTOTOXICITY; GENE THERAPY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; MINK CELL FOCUS-FORMING VIRUS;

EID: 0032891550     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400498     Document Type: Article

References (28)

1. Sherr CJ (1996) Cancer cell cycles. Science 274: 1672-1677
2. Bowen ID (1993) Apoptosis or programmed cell death? Cell Biol. Int. 17: 365-380
3. Heintz N (1993) Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem. Sci. 18: 157-159
4. Li Z, Rakkar A, Katayose Y, Kim M, Shanmugam N, Moul JW, McLeod DG, Cowan KH and Seth P (1997) Efficacy of multiple administrations of a recombinant adenovirus expressing wild type p53 in an immune-competent mouse tumor model. Gene Ther. 5: 605-613
5. Rakkar A, Katayose Y, Li Z, Cowan KH and Seth P (1998) Cancer gene therapy using a recombinant adenoviral vector expressing a cyclin kinase inhibitor p27/ Kip1 in a breast cancer model. J. Natl. Cancer Institute (in press)
6. Katayose D, Gudas J, Nguyen JH, Srivastava S, Cowan KH and Seth P (1995) Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1: 889-897
7. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
8. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). Embo J. 16: 2794-2804
9. Medema JP, Toes RE, Scaffidi C, Zheng TS, Flavell RA, Melief CJ, Peter ME, Offringa R and Krammer PH (1997) Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis. Eur. J. Immunol. 27: 3492-3498
10. Roberts RA, Nebert DW, Hickman JA, Richburg JH and Goldsworthy TL (1997) Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl.Toxicol. 38: 107-115
11. Spataro V (1998) Recent advances in the molecular genetics of cancer. Second joint conference of the American Association of Cancer Research and the European Association of Cancer Research, Oxford, 9-12 September 1997. Ann. Oncol. 9: 23-29
12. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E et al (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15: 3032-3040
13. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413
14. Yonehara S, Ishii A and Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756
15. Katayose D, Wersto R, Cowan KH and Seth P (1995) Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ. 6: 1207-1212
16. Sherwood SW and Schimke RT (1995) Cell cycle analysis of apoptosis using flow cytometry. Methods Cell Biol. 46: 77-97
17. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N (1995) Induction of the growth inhibitor IGF-binding protein by 3 by p53. Nature 377: 646-649
18. Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 8: 293-299
19. Komada Y and Sakurai M (1997) Fas receptor (CD95)-mediated apoptosis in leukemiccells. Leuk. Lymphoma 25: 9-21
20. Leithauser F, Dhein D, Mechtersheimer G, Koretz K, Brunderlein S, Henne C, Schmidt A, Debatin K, Krammer P and Moller P (1993) Constitutive and induced expression of APO-1, a member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and malignant cells. Lab. Invest. 69: 415-429
21. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A and Krammer PH (1994) Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer 57: 371-377
22. Keane MM, Ettenberg SA, Lowery GA, Russell EK and Lipkowitz S (1996) Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56: 4791-4798
23. Hughes SJ, Nambu Y, Soldes OS, Hamstra D, Rehemtulla A, Iannettoni MD, Orringer MB and Beer DG (1997) Fas/APO-1 (CD95) is nottranslocated to the cell membrane in esophageal adenocarcinoma. Cancer Res. 57: 5571-5578
24. von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH and Moller P (1998) Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res. 58: 526-534
25. Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze M, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmot RW, Boucher RC et al (1997) Human gene marker/therapy clinical protocols. Hum. Gene Ther. 8: 2301-2338
26. Craig C, Wersto R, Kim M, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K and Seth P (1997) A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14: 2283-2289
27. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan K and Seth P (1997) Promoting apoptosis: A novel activity associated with cyclin-dependent kinase inhibitor p27. Cancer Res. 57: 5441-5444
28. Kim M, Lee YS, Mathews HL and Wurster RD (1997) Induction of apoptotic cell death in a neuroblastoma cell line by dibucaine. Exp. Cell Res. 231: 235-241